2C-T-19 (2,5-dimethoxy-4-butylthiophenethylamine) is a psychedelic phenethylamine of the 2C family. It was first synthesized by Alexander Shulgin.
Names | |
---|---|
Preferred IUPAC name
2-[4-(Butylsulfanyl)-2,5-dimethoxyphenyl]ethan-1-amine | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C14H23NO2S | |
Molar mass | 269.40 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Dosage
editIn his book PiHKAL, Shulgin describes synthesis of the final intermediate of 2C-T-19 but did not bioassay the compound.[1]
Legality
editCanada
editAs of October 31, 2016, 2C-T-19 is a controlled substance (Schedule III) in Canada.[2]
United States
editIn the United States, 2C-T-19 is not specifically scheduled, but possession and sales of 2C-T-19 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.
References
edit- ^ 2C-T-21 Entry in PiHKAL, mentioning 2C-T-19
- ^ "Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". Canada Gazette. Vol. 150, no. 9. 4 May 2016.